» Articles » PMID: 33710133

Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer

Overview
Journal Am J Clin Oncol
Specialty Oncology
Date 2021 Mar 12
PMID 33710133
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Most patients with pancreatic cancer have high symptom burden and poor outcomes. Palliative care (PC) can improve the quality of care through expert symptom management, although the optimal timing of PC referral is still poorly understood. We aimed to assess the association of early PC on health care utilization and charges of care for pancreatic cancer patients.

Materials And Methods: We selected patients with pancreatic cancer diagnosed between 2000 and 2009 who received at least 1 PC encounter using the Surveillance, Epidemiology, and End Results (SEER)-Medicare. Patients who had unknown follow-up were excluded. We defined "early PC" if the patients received PC within 30 days of diagnosis.

Results: A total of 3166 patients had a PC encounter; 28% had an early PC. Patients receiving early PC were more likely to be female and have older age compared with patients receiving late PC (P<0.001). Patients receiving early PC had fewer emergency department (ED) visits (2.6 vs. 3.0 visits, P=0.004) and lower total charges of ED care ($3158 vs. $3981, P<0.001) compared with patients receiving late PC. Patients receiving early PC also had lower intensive care unit admissions (0.82 vs. 0.98 visits, P=0.006) and total charges of intensive care unit care ($14,466 vs. $18,687, P=0.01). On multivariable analysis, patients receiving early PC were significantly associated with fewer ED visits (P=0.007) and lower charges of ED care (P=0.018) for all patients.

Conclusions: Early PC referrals were associated with lower ED visits and ED-related charges. Our findings support oncology society guideline recommendations for early PC in patients with advanced malignancies such as pancreatic cancer.

Citing Articles

The Paradox of Palliative Care at the End of Life: Higher Rates of Aggressive Interventions in Patients with Pancreatic Cancer.

Zhang Z, Gokul K, Hinyard L, Subramaniam D J Clin Med. 2024; 13(17).

PMID: 39274498 PMC: 11395880. DOI: 10.3390/jcm13175286.


Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era.

Lee D, McNamara M, Yang A, Yaskolko M, Kluger H, Tran T Pigment Cell Melanoma Res. 2024; 37(6):847-853.

PMID: 39073002 PMC: 11809125. DOI: 10.1111/pcmr.13188.


Predicting Patient Mortality for Earlier Palliative Care Identification in Medicare Advantage Plans: Features of a Machine Learning Model.

Bowers A, Drake C, Makarkin A, Monzyk R, Maity B, Telle A JMIR AI. 2024; 2:e42253.

PMID: 38875557 PMC: 11041411. DOI: 10.2196/42253.


Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review.

Habib M, Tiger Y, Dima D, Schlogl M, McDonald A, Mazzoni S J Clin Med. 2024; 13(7).

PMID: 38610755 PMC: 11012321. DOI: 10.3390/jcm13071991.


Association of Inpatient Palliative Care Consultation with Clinical and Financial Outcomes for Pancreatic Cancer.

Kim S, Chervu N, Premji A, Mallick S, Verma A, Ali K Ann Surg Oncol. 2023; 31(2):1328-1335.

PMID: 37957512 DOI: 10.1245/s10434-023-14528-7.